Results 261 to 270 of about 116,541 (310)

Gingival and Periodontal Diseases and Conditions in Children and Adolescents: Consensus Report

Journal of Clinical Periodontology, Volume 53, Issue 7, Page 1068-1099, July 2026.
ABSTRACT Background The objectives of this Focused Workshop were to update the epidemiology, aetiology, risk factors, diagnosis and management of gingival and periodontal diseases and conditions in children and adolescents, and to explore the applicability of the 2018 Classification in children and adolescents.
Iain Chapple, Sotiria Gizani, Mariano Sanz, Dominique Declerck, Phoebus Madianos, Valerie Clerehugh, Monique Danser, Esti Davidovich, Janet Davies, Nikos Donos, Elisabeth Dursun, Elena Figuero, Filippo Graziani, Mervi Gursoy, Soren Jepsen, Clara Joseph, Moritz Kebschull, Norbert Kraemer, Tina Lambrinaki, Rodrigo López, David J. Manton, Joerg Meyle, Ana Molina, Lior Shapira, Cheryl Somani, Georgios Tsilingaridis, Svante Twetman, Nicola West, Biniyam Wondimu, Ferranti Wong, David Herrera   +30 more
wiley   +1 more source

Educational inequalities in cervical cancer mortality in the Baltic countries and Finland in the context of organized screening: A register‐based study 2000–2015

International Journal of Cancer, Volume 158, Issue 12, Page 3132-3140, 15 June 2026.
What's new? This study shows that absolute and relative educational inequalities in cervical cancer mortality are much larger in the Baltic countries than in Finland, where an organized screening programme was introduced more than 40 years earlier. After the introduction of organized screening, cervical cancer mortality declined among low‐educated ...
Oskar Nõmm, Kaire Innos, Domantas Jasilionis, Juris Krumins, Pekka Martikainen, Kersti Pärna, Andrew Stickley, Mall Leinsalu   +7 more
wiley   +1 more source

Cost‐effectiveness analysis of human papillomavirus (HPV) genotyping strategies for management of HPV‐positive women in cervical cancer screening

International Journal of Cancer, Volume 158, Issue 12, Page 3141-3151, 15 June 2026.
What's new? Persistent infection with high‐risk human papillomavirus (HPV) causes most invasive cervical cancer cases, leading many countries to transition from cytology to primary HPV‐based screening. Despite the benefits, HPV‐based screening may also lead to unnecessary procedures, psychological burden, and strain on healthcare systems.
Kelsi R. Kroon, Johannes A. Bogaards, Johannes Berkhof   +2 more
wiley   +1 more source

Immunoinformatics approach for design novel multi-epitope prophylactic and therapeutic vaccine based on capsid proteins L1 and L2 and oncoproteins E6 and E7 of human papillomavirus 16 and human papillomavirus 18 against cervical cancer. [PDF]

Osong Public Health Res Perspect
Ryan N, Pratiwi SE, Mardhia M, Ysrafil Y, Liana DF, Mahyarudin M.   +5 more
europepmc   +1 more source

Health care policy trial of primary human papillomavirus–based cervical screening in Denmark: Comparison of three triage algorithms

International Journal of Cancer, Volume 158, Issue 12, Page 3197-3207, 15 June 2026.
What's new? Primary human papillomavirus (HPV)–based screening has shown superiority to cytology‐based screening in reducing cervical cancer risk in clinical trials. However, the benefit must be balanced with potential overdiagnosis/overtreatment.
Jeppe Bennekou Schroll, Jesper Bonde, Elsebeth Lynge, Marianne Waldstrøm, Petra Hall Viborg, Anna Frandsen, Rikke Holst Andersen, Susanne Merete Nielsen, Bettina Kjær Kristensen, Doris Schledermann, Berit Andersen, on behalf ofthe National Danish Cervical Cancer Screening Steering Committee   +11 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Susceptibility of human papillomavirus 16 to disinfectants

Infection Control & Hospital Epidemiology, 2021
Endocavitary ultrasound probes are commonly used to assess the pelvis (eg, prostate or uterus) via the vagina or anus and are routinely contaminated with vaginal or rectal microbes that may also include human papilloma virus (HPV). As a result, these probes require cleaning followed by high-level disinfection after use.
Moody, Cary A., Weber, David J., Sickbert-Bennett, Emily E., Anderson, Deverick J., Gergen, Maria F., Rutala, William A.   +5 more
openaire   +2 more sources

Human papillomavirus type 16 DNA sequence

Virology, 1985
The complete nucleotide sequence of HPV16 DNA (7904 bp) cloned from an invasive cervical carcinoma was determined. Homology comparisons allowed us to align the major open reading frames with the other published papilloma virus DNA sequences. The general organization of the open reading frames is similar to that of the other four papillomavirus (BPV1 ...
K, Seedorf, G, Krämmer, M, Dürst, S, Suhai, W G, Röwekamp   +4 more
openaire   +2 more sources

Seroprevalence of Human Papillomavirus Type 16 in Children

The Journal of Infectious Diseases, 2005
We evaluated the prevalence of antibodies to human papillomavirus (HPV) type 16 in a representative sample of children 6-11 years of age in the United States. Serum samples and questionnaire data were collected between 1991 and 1994, for the National Health and Nutrition Examination Survey III.
Eileen F, Dunne, Kevin L, Karem, Maya R, Sternberg, Katherine M, Stone, Elizabeth R, Unger, William C, Reeves, Lauri E, Markowitz   +6 more
openaire   +2 more sources

Glycosylation of Human Papillomavirus Type 16 L1 Protein

Virology, 1993
We examined glycosylation of the L1 capsid protein of human papillomavirus type 16, using HPV16 L1 protein expressed from various recombinant vaccinia viruses in CV-1 and HaCaT cells. A minority of L1 protein was N-glycosylated, and all four potential N-glycosylation sites appeared to be used.
Zhou, J, Sun, XY, Frazer, IH
openaire   +5 more sources